Literature DB >> 25308023

Bilateral synchronous high-grade serous carcinoma and clear cell carcinoma in right and left ovaries with immunohistochemical confirmation: an exceptional finding.

Agarwal Preeti1, Kumar Arun Arunachalam, Yashodhara Pradeep, Goel Madhu Mati.   

Abstract

Synchronous epithelial or mixed epithelial and germ cells tumors in the same ovary is a recognized event, however, having two different surface epithelial tumors in contra lateral ovaries is a rare occurrence; prognosis and pathogenesis of which is still not clear. We came across similar finding in a 60-year-old female with different types of surface epithelial neoplasm in right and left ovaries at the same time; both of which were malignant. Clinicoradiologically only the left ovary revealed tumor, right ovary was atrophic. To our surprise, left ovary revealed high grade serous carcinoma and the right ovary displayed clear cell carcinoma. We performed immunohistochemistry to rule out the possibility of clear cell variant of serous papillary carcinoma. On literature search, we found; only single case with synchronous presentation of two different surface epithelial ovarian tumors in the same patient, both of which were benign.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25308023     DOI: 10.4103/0377-4929.142706

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  2 in total

1.  A Rare Report of Concurrent Serous and Mucinous Cystadenomas in Bilateral Ovaries.

Authors:  Krishnendu Mondal; Tarak Banik; Rupali Mandal
Journal:  J Obstet Gynaecol India       Date:  2016-12-30

Review 2.  Synchronous bilateral primary ovarian cancer with right endometroid carcinoma and left high-grade serous carcinoma: a case report and literature review.

Authors:  Mimori Fujimori; Toshifumi Takahashi; Yuka Furukawa; Atsuhiro Takanashi; Yoshiyuki Iizawa; Masatoshi Jimbo; Shu Soeda; Keiya Fujimori; Kazuyuki Takeichi
Journal:  BMC Womens Health       Date:  2022-04-05       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.